Anzeige
Mehr »
Login
Dienstag, 23.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N6ZF | ISIN: US03528H1095 | Ticker-Symbol: CY71
Frankfurt
23.04.24
08:00 Uhr
2,780 Euro
-0,120
-4,14 %
Branche
Bekleidung/Textil
Aktienmarkt
Sonstige
1-Jahres-Chart
ANIXA BIOSCIENCES INC Chart 1 Jahr
5-Tage-Chart
ANIXA BIOSCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,7802,90014:28
2,7802,90013:25

Aktuelle News zur ANIXA BIOSCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.03.Anixa Biosciences Inc - 8-K, Current Report4
15.03.Anixa Biosciences director Arnold M. Baskies buys $36,300 in company stock3
15.03.Anixa Biosciences CEO Amit Kumar buys $96,600 in company stock3
12.03.Recap: Anixa Biosciences Q1 Earnings1
12.03.Anixa Biosciences Inc - 10-Q, Quarterly Report1
12.02.Anixa Biosciences, Inc.: Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial562Dose escalation for fourth patient follows successful completion of first cohort SAN JOSE, Calif., Feb. 12, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX)...
► Artikel lesen
23.01.Anixa ovarian cancer vaccine tech gets Japanese patent5
23.01.Anixa Biosciences, Inc.: Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology367Broad coverage extended to Japan and related regions SAN JOSE, Calif., Jan. 23, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology...
► Artikel lesen
16.01.Anixa Biosciences Inc - S-8, Securities to be offered to employees in employee benefit plans2
16.01.Anixa Biosciences Inc - 10-K, Annual Report2
20.12.23Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?8
07.12.23Anixa Bio falls after Phase 1 data for breast cancer vaccine4
07.12.23Anixa Biosciences Inc - 8-K, Current Report2
07.12.23Anixa Biosciences Announces Positive Data From Phase 1 Study Of Breast Cancer Vaccine; Stock Up5
27.11.23Anixa Gains on European Patent4
10.08.23Anixa Biosciences, Inc.: Could Anixa Biosciences Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?651SAN JOSE, CA / ACCESSWIRE / August 10, 2023 / Cancer is a disease that affects millions of people around the world. Historically, cancer vaccines have not been very successful in treating or preventing...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1